Skip to main content
. 2023 Nov 17;14:1256232. doi: 10.3389/fendo.2023.1256232

Table 3.

ATA risk classification according to the responses to therapy.

ATA risk classification n (%) Excellent response (n = 461) Indeterminate response (n = 65) Biochemicalincomplete response (n = 83) Structural incomplete (n = 65) p-values
Low risk 404 (60.0%) 318 (68.9%) 36 (55.4%) 44 (53.0%) 6 (9.2%) <0.001
Intermediate risk 127 (18.8%) 76 (16.5%) 14 (21.5%) 18 (21.7%) 19 (29.2%)
High risk 143 (21.2%) 67 (14.5%) 15 (23.1%) 21 (25.3%) 40 (61.5%)

Significant differences in the proportions (p-value) were determined by chi-square analysis.

ATA, American Thyroid Association.